Skip to main content
Premium Trial:

Request an Annual Quote

IRRI Buys Genomic Solutions GeneTAC System

NEW YORK, Oct. 2 – The International Rice Research Institute has purchased a GeneTAC Biochip System, Genomic Solutions, the developer of the microarray system said Tuesday.

Genomic Solutions said that the IRRI of Los Baños, Phillippines plans to use the system as part of its plans to establish a new microarray facility. 

The IRRI said that the facility would help to further researchers’ understanding of rice genomics.

“One of our objectives is to promote accessibility of genomic tools to rice research institutions in developing countries,” said Hei Leung, the director of IRRI’s functional genomics project.  

“With the establishment of the microarray facility at IRRI, we are in a better position to provide research support and training to our partners," Leung said.

IRRI was created in 1960 with funds from the Ford Rockefeller Foundation. In the mid 1960s, IRRI developed the first semidwarf breeding lines for rice, a high yield grain that was rapidly adopted in Asia. The institute now employs over 1,000 research and support staff.

In addition to buying the GeneTAC system, the IRRI has also acquired reagents from PerkinElmer, the exclusive distributor of Genomic Solutions’ products.

Financial terms of the deal were not disclosed.

The Scan

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.

Study Explores Animated Digital Message Approach to Communicate Genetic Test Results to Family Members

In the Journal of Genetic Counseling, the approach showed promise in participants presented with a hypothetical scenario related to a familial hereditary breast and ovarian cancer syndrome diagnosis.

Computational Tool Predicts Mammalian Messenger RNA Degradation Rates

A tool called Saluki, trained with mouse and human messenger RNA data, appears to improve mRNA half-life predictions by taking RNA and genetic features into account, a Genome Biology paper reports.

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.